Gapping up
In reaction to strong earnings/guidance:
- ENPH +18.5%, NUS +18%, ARLO +10.1% (also enters cooperation agreement with VIEX Capital), TNDM +8.4%, MTOR +7%, AKAM +6.2%, SLCA +6.1%, ROG +5.8%, CVS +5.8%, TWLO +5.7%, TWST +5.7%, AAPL +5.5%, VCYT +5.2%, AMD +5.1%, CBL +5%, IPHI +4.8%, EOLS +4.6%, HUBG +4.6%, EL +4.5%, LSCC +4.2%, NANO +4.1%, GRPN +4%, TDOC +3.5%, SPR +3.5%, MX +3.4%, OSIS +3.3%, COOP +3.3%, HRS +3.3%, ACHC +3.1%, AMCX +3.1%, SOI +2.9%, TMHC +2.9%, HLT +2.8%, JCI +2.7%, QUAD +2.4%, UDR +2.3%, TCO +2.2%, MGRC +1.6%, RDWR +1.6%, LLL +1.6%, MRCY +1.3%, AJRD +1.2%, MDLZ +1.2%, DVN +1.1%, LKSD +1.1%, HUM +1.1%
M&A news:
- AMN +1.3% (to acquire Advanced Medical Personnel Services for purchase price of $200 mln)
Select AAPL related names showing strength:
- LITE +1.8%, CRUS +1.8%, NVDA +1.6%, STM +1.6%, QRVO +1.3%, QCOM +1.2%, SMH +1%, QQQ +0.7%, XLK +0.7%
Other news:
- EYPT +13.5% (presents data supporting YUTIQ 0.18 mg three-year micro-insert for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye
- CKPT +11.9% (announces 'positive' interim results from ongoing multicenter Phase 1 clinical trial of cosibelimab)
- MAC +0.9% (discloses adoption of governance enhancements)
- AMZN +0.5% (Amazon Web Services announces general availability of Amazon Managed Blockchain)
- BRK.B +0.5% (large shareholder trading higher with Apple)
Analyst comments:
- LL +4.4% (upgraded to Outperform from Mkt Perform at Raymond James)
- STX +2.4% (upgraded to Buy from Hold at The Benchmark Company)
- TTWO +2.2% (upgraded to Outperform from Market Perform at Cowen)
- SABR +1.6% (upgraded to Buy from Neutral at BofA/Merrill)
- GLW +1.5% (upgraded to Buy from Neutral at BofA/Merrill)
- LYFT +1.1% (initiated with Buy at Tigress Research)
- NXPI +0.9% (target raised to $125 from $105 at BofA/Merrill; added to US 1 List)